137 related articles for article (PubMed ID: 12571522)
1. Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir.
Dieleman JP; van Rossum AM; Stricker BC; Sturkenboom MC; de Groot R; Telgt D; Blok WL; Burger DM; Blijenberg BG; Zietse R; Gyssens IC
J Acquir Immune Defic Syndr; 2003 Feb; 32(2):135-42. PubMed ID: 12571522
[TBL] [Abstract][Full Text] [Related]
2. Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavir.
van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Burger DM; Gyssens IC; de Groot R
Pediatrics; 2002 Aug; 110(2 Pt 1):e19. PubMed ID: 12165618
[TBL] [Abstract][Full Text] [Related]
3. The natural history of leukocyturia associated with indinavir treatment in HIV+ individuals.
Gagnon RF; Tecimer SN; Watters AK; Hatzakis GE; Tsoukas CM
Am J Nephrol; 2000; 20(6):448-54. PubMed ID: 11146311
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.
Avihingsanon A; Avihingsanon Y; Darnpornprasert P; Kerr S; Ungsedhapand C; Duncombe C; Ubolyam S; Ruxrungtham K; Phanuphak P
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S21-7. PubMed ID: 17044450
[TBL] [Abstract][Full Text] [Related]
5. Changes in renal function associated with indinavir.
Boubaker K; Sudre P; Bally F; Vogel G; Meuwly JY; Glauser MP; Telenti A
AIDS; 1998 Dec; 12(18):F249-54. PubMed ID: 9875572
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir.
Gagnon RF; Tecimer SN; Watters AK; Tsoukas CM
Am J Kidney Dis; 2000 Sep; 36(3):507-15. PubMed ID: 10977782
[TBL] [Abstract][Full Text] [Related]
7. Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.
Trainor LD; Steinberg JP; Austin GW; Solomon HM
Arch Pathol Lab Med; 1998 Mar; 122(3):256-9. PubMed ID: 9823864
[TBL] [Abstract][Full Text] [Related]
8. Low urine pH is associated with reduced indinavir crystalluria in indinavir-treated HIV-infected individuals.
Gagnon RF; Alli AI; Edwardes MD; Watters AK; Tsoukas CM
Clin Nephrol; 2006 Jan; 65(1):13-21. PubMed ID: 16429837
[TBL] [Abstract][Full Text] [Related]
9. Indinavir crystalluria.
Gagnon RF; Alli AI; Watters AK; Tsoukas CM
Kidney Int; 2006 Dec; 70(12):2047. PubMed ID: 17136127
[No Abstract] [Full Text] [Related]
10. Urinary NO3 excretion and renal failure in indinavir-treated patients.
Eira M; Araujo M; Seguro AC
Braz J Med Biol Res; 2006 Aug; 39(8):1065-70. PubMed ID: 16906281
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic crystalluria associated with indinavir.
Famularo G; Di Toro S; Moretti S; De Simone C
Ann Pharmacother; 2000 Dec; 34(12):1414-8. PubMed ID: 11144699
[TBL] [Abstract][Full Text] [Related]
12. Effects of escin on indinavir crystallization time in the urine of patients with HIV-I infection: a multicenter, randomized, open-label, controlled, four-period crossover trial.
Grases F; García-González R; Redondo E; Costa-Bauzá A; Simonet BM; Sartini RP; Bassa A; Gallegos C; Payeras A; Saro D; Martinez AI; Cifuentes C; Homar F; Murillo JA; Fernández C; Riera M; Conte A
Clin Ther; 2004 Dec; 26(12):2045-55. PubMed ID: 15823768
[TBL] [Abstract][Full Text] [Related]
13. Pyuria in patients treated with indinavir is associated with renal dysfunction.
Sarcletti M; Petter A; Romani N; Lhotta K; König P; Maier H; Zangerle R
Clin Nephrol; 2000 Oct; 54(4):261-70. PubMed ID: 11076101
[TBL] [Abstract][Full Text] [Related]
14. [Indinavir-associated tubulointerstitial renal disease].
Gagnon RF; Mehio A; Iqbal S; Tsoukas CM
Nephrol Ther; 2007 Dec; 3(7):461-2. PubMed ID: 18048001
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity.
Wasmuth JC; Lambertz I; Voigt E; Vogel M; Hoffmann C; Burger D; Rockstroh JK
Eur J Clin Pharmacol; 2007 Oct; 63(10):901-8. PubMed ID: 17690876
[TBL] [Abstract][Full Text] [Related]
16. Crystalluria and urinary tract abnormalities associated with indinavir.
Kopp JB; Miller KD; Mican JA; Feuerstein IM; Vaughan E; Baker C; Pannell LK; Falloon J
Ann Intern Med; 1997 Jul; 127(2):119-25. PubMed ID: 9230000
[TBL] [Abstract][Full Text] [Related]
17. Acute tubulointerstitial nephritis attributable to indinavir therapy.
Jaradat M; Phillips C; Yum MN; Cushing H; Moe S
Am J Kidney Dis; 2000 Apr; 35(4):E16. PubMed ID: 10739809
[TBL] [Abstract][Full Text] [Related]
18. HIV/AIDS case histories: indinavir crystalluria.
Godwin TA
AIDS Patient Care STDS; 2001 Mar; 15(3):169-71. PubMed ID: 11313030
[No Abstract] [Full Text] [Related]
19. The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity.
Boyd MA; Siangphoe U; Ruxrungtham K; Reiss P; Mahanontharit A; Lange JM; Phanuphak P; Cooper DA; Burger DM
J Antimicrob Chemother; 2006 Jun; 57(6):1161-7. PubMed ID: 16595641
[TBL] [Abstract][Full Text] [Related]
20. Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors.
Reilly RF; Tray K; Perazella MA
Am J Kidney Dis; 2001 Oct; 38(4):E23. PubMed ID: 11576910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
